<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Fruhmann, Gernot</dc:creator>
  <dc:creator>Marchal, Christelle</dc:creator>
  <dc:creator>Vignaud, Hélène</dc:creator>
  <dc:creator>Verduyckt, Mathias</dc:creator>
  <dc:creator>Talarek, Nicolas</dc:creator>
  <dc:creator>De Virgilio, Claudio</dc:creator>
  <dc:creator>Winderickx, Joris</dc:creator>
  <dc:creator>Cullin, Christophe</dc:creator>
  <dc:date>2018</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Aβ metabolism plays a pivotal role in Alzheimer’s disease. Here, we used a yeast  model to monitor Aβ42 toxicity when entering the secretory pathway and demonstrate  that processing in, and exit from the endoplasmic reticulum (ER) is required to  unleash the full Aβ42 toxic potential. Consistent with previously reported data, our  data suggests that Aβ42 interacts with mitochondria, thereby enhancing formation of  reactive oxygen species and eventually leading to cell demise. We used our model to  search for genes that modulate this deleterious effect, either by reducing or enhancing  Aβ42 toxicity, based on screening of the yeast knockout collection. This revealed a  reduced Aβ42 toxicity not only in strains hampered in ER-Golgi traffic and  mitochondrial functioning but also in strains lacking genes connected to the cell cycle  and the DNA replication stress response. On the other hand, increased Aβ42 toxicity  was observed in strains affected in the actin cytoskeleton organization, endocytosis  and the formation of multivesicular bodies, including key factors of the ESCRT  machinery. Since the latter was shown to be required for the repair of membrane  lesions in mammalian systems, we studied this aspect in more detail in our yeast  model. Our data demonstrated that Aβ42 heavily disturbed the plasma membrane  integrity in a strain lacking the ESCRT-III accessory factor Bro1, a phenotype that  came along with a severe growth defect and enhanced loading of lipid droplets. Thus,  it appears that also in yeast ESCRT is required for membrane repair, thereby  counteracting one of the deleterious effects induced by the expression of Aβ42.  Combined, our studies once more validated the use of yeast as a model to investigate  fundamental mechanisms underlying the etiology of neurodegenerative disorders.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307324</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307324/files/vir_iea.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307324/files/vir_iea_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3389/fnmol.2018.00406</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Frontiers in Molecular Neuroscience. - 2018, vol. 11, p. 406</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">The impact of ESCRT on Aβ1-42 induced membrane lesions in a yeast model for Alzheimer’s disease</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
